Plant Intelligence
The endocannabinoid system did not arrive with you. It arrived with your ancestors — hundreds of millions of years before the first human being existed. Every vertebrate animal on earth runs a version of it. It was already ancient before your species had a name for it.
Plants were producing bioactive compounds long before animal life developed the receptors to receive them. Why the compatibility between plant chemistry and animal biology runs so deep is a question scientists haven’t fully settled. One possibility: the ECS evolved independently, for its own internal regulatory reasons, and the overlap with plant compounds is a fortunate molecular coincidence. Another possibility — and one worth taking seriously — is that animal biology evolved in a world already saturated with plant chemistry, and the two systems shaped each other over hundreds of millions of years, much the way plants and animals co-evolved to exchange oxygen and CO2. Neither gives, neither takes — both thrive.
The honest answer is: we don’t know yet. What we do know is that the compatibility is real, it is ancient, and it is the foundation of everything on this page.
The Molecular Handshake
Your body is already running a cannabinoid system. It has been your entire life.
It doesn’t announce itself. But right now, woven into your nervous system and extending far beyond it — into your immune cells, your gut, your skin, and your bones — a network of receptors and molecular signals is quietly doing one of the most important jobs in your biology: making sure nothing goes too far.
That network is called the endocannabinoid system — the ECS. It is not separate from your nervous system. It is part of it — specifically, it is a neuromodulatory system, meaning its job is to regulate how your nervous system communicates with itself. When signals become too loud, too persistent, or too dysregulated, the ECS steps in to recalibrate. It is the reason your body doesn’t spiral endlessly into pain, inflammation, anxiety, or sleeplessness when those systems are triggered. It is, in the most literal biological sense, your body’s mechanism for balance.
Understanding how it works changes how you think about everything from chronic pain to sleep to mood to immune response.
Your Body’s Built-In Volume Control
Most signaling in your nervous system travels in one direction. Neuron A fires a chemical signal. Neuron B receives it. Message delivered.
The ECS works differently — and that difference is everything.
When a signal in your body becomes too loud — too much pain, too much inflammation, too much stress response — the receiving neuron does something unusual. It manufactures its own chemical messengers on the spot and sends them backward, upstream, to the neuron that started the noise. Those messengers bind to receptors on the sending neuron and essentially say: dial it back.
This is called retrograde signaling — and it is one of the most elegant regulatory mechanisms in your body.
But where do these messengers come from? Not from storage. Not from some reserve your body maintains for emergencies. Your endocannabinoids are built from scratch, at the moment they’re needed, from the cell’s own membrane. Every cell in your body is bounded by a membrane made partly of phospholipids — fatty molecules that give the membrane its structure. When a receiving neuron is overwhelmed, enzymes in that membrane convert those phospholipids into endocannabinoids right there, at the site of the signal, in real time. The cell essentially transforms part of its own architecture into a messenger. Once that messenger has done its job, other enzymes break it down quickly and completely. Nothing lingers. Nothing accumulates. The response is precise, local, and temporary — calibrated to exactly what the moment requires.
What Receptors Are — and Where They Are
Your body produces two primary endocannabinoids this way: Anandamide (named after the Sanskrit word for bliss) influences mood, memory, and pain perception, and 2-AG regulates inflammation, immune response, and neurological activity. Together, they are the ECS’s primary chemical language: synthesized on demand, deployed with precision, and cleared away cleanly when their work is done.What Receptors Are — and Where They Are
For any chemical messenger to do its job, it needs somewhere to land. In the ECS, that means receptors.
A receptor is a protein embedded in the surface of a cell membrane, shaped specifically to receive a particular molecular signal, the way a lock is shaped for a particular key. When the right molecule binds to a receptor, it triggers a response inside the cell: a change in activity, a shift in output, a recalibration of what that cell is doing. Receptors don’t generate signals themselves. They receive them, interpret them, and act on them.
CB1 receptors are concentrated in your brain and central nervous system. You’ll find them in the hippocampus, which governs memory and learning; the amygdala, which processes emotion — including the fear and stress responses that feed directly into pain and inflammation; the cerebral cortex, which handles cognition and decision-making; the cerebellum, which coordinates movement; and the basal ganglia, which are involved in motivation and reward. CB1 receptors are also present throughout your peripheral nervous system — the network of nerves running through your body outside the brain and spinal cord — where they play a significant role in pain signaling. And they extend further still: into your liver, your fat tissue, your muscles, and your gastrointestinal tract, where they regulate motility, secretion, and local inflammation.
The ECS has two primary receptor types: CB1 and CB2. Where they’re located tells you exactly what the ECS governs — and the answer is far broader than most people expect.
CB2 receptors tell a different story. Their primary home is your immune system — and this is where the ECS becomes particularly compelling for anyone managing chronic inflammation. CB2 receptors are dense in your spleen, your tonsils, and your bone marrow — the core infrastructure of immune response. They’re present in your peripheral nervous system, your gastrointestinal tract, your bone tissue where they influence bone density and remodeling, and your skin, where they participate in wound healing and inflammatory response.
Read that list again: Memory. Emotion. Pain. Immune function. Inflammation. Digestion. Bone density. Skin repair.
This is not a niche system. This is a system that touches nearly every major function your body performs — and it is running continuously, whether you are aware of it or not.
Where Plants Enter the Picture
Phytocannabinoids — cannabinoids produced by plants — interact with this same receptor architecture. And cannabis is not the only plant that produces them.
Cannabinoid-like compounds have been identified across the plant kingdom: in black pepper, whose beta-caryophyllene binds directly to CB2 receptors; in echinacea, long used to support immune function; in cacao, which contains compounds that slow the breakdown of anandamide — your own bliss molecule — allowing it to remain active longer; and in black truffles, among others. Plants have been producing these molecules for hundreds of millions of years, long before humans thought to look for them.
Cannabis, however, produces phytocannabinoids with a structural precision and concentration that few other plants can match. Its compounds bind to CB1 and CB2 receptors with a specificity that makes it uniquely capable of interacting with the ECS — not by overriding the system, but by working within its existing architecture. Some phytocannabinoids closely resemble your own endocannabinoids in structure, fitting the same receptors and triggering similar responses. Others work more indirectly: modulating how receptors respond, slowing the enzymatic breakdown of your endocannabinoids, or influencing adjacent pathways that feed back into ECS function.
This is not a hack. It is not a workaround. It is a molecular conversation between two biological systems that have been speaking the same language for hundreds of millions of years.
Your body already knows how to listen. Phytocannabinoids give it something worth hearing.
Why Certain Plants Are More Beneficial Than Others
Not all plants are created equal — at least not from the perspective of your endocannabinoid system.
The plant kingdom is vast, and a remarkable number of its members produce compounds that interact with human biology in meaningful ways. But interaction is not the same as precision. What determines how beneficial a plant compound is to your ECS comes down to three things: how specifically it binds to your receptors, how abundantly the plant produces it, and how effectively your body can absorb and use it. By all three measures, some plants are simply better equipped than others — and understanding why tells you something important about how to think about botanical medicine generally.
The Question of Fit
Remember the lock-and-key analogy from the previous section. A receptor is a lock shaped for a very specific molecular key. The closer the fit, the stronger and more targeted the response. A poor fit produces a weak signal, an incomplete response, or no meaningful interaction at all.
Most plants that produce cannabinoid-like compounds do so at low concentrations and with imprecise receptor fit. They interact with the ECS, but loosely — more like a skeleton key that rattles around in the lock than one cut for it specifically. This doesn’t make them useless. It makes them useful in a different way: as supporting players in a broader botanical picture rather than primary actors.
Black pepper contains beta-caryophyllene — a compound that binds directly and selectively to CB2 receptors. That’s genuinely specific receptor interaction, and we’ll look at it more closely in the terpene section. But the concentration you’d need to produce meaningful therapeutic effect goes well beyond what you’d get from seasoning your food. It matters. It’s real. But it is not a substitute for compounds produced in therapeutic concentrations.
Echinacea produces alkylamides — compounds that interact with both CB1 and CB2 receptors and have been studied for their immune-modulating effects. This is likely part of the reason echinacea has been used for immune support for centuries: the traditional use preceded the science, but the science eventually caught up.
Cacao contains compounds that inhibit the enzyme responsible for breaking down anandamide — your body’s own bliss molecule — effectively extending its activity and allowing your ECS to function more efficiently without introducing any external cannabinoid at all. If you have ever wondered why good chocolate produces something that feels like more than simple pleasure, this is part of the answer. The effect is real. The mechanism is documented. And it has nothing to do with sugar.
Black truffles produce anandamide directly, though in quantities too small to produce significant physiological effect in humans.
Yangonin, one of kava’s compounds, does bind to CB1 receptors — but it is one compound among several, and kava’s primary anxiety-reducing mechanism operates through GABA receptors, not the ECS. The ECS connection is real but partial — worth knowing, not worth overstating.
Each of these is worth knowing. None of them operates with the precision or concentration of cannabis — which brings us to why cannabis stands apart.
Why Cannabis Stands Apart
Cannabis produces over 100 distinct phytocannabinoids — a diversity of compounds unmatched in the plant kingdom. More importantly, it produces them in concentrations high enough to produce measurable physiological effects. And structurally, several of its primary cannabinoids fit human CB1 and CB2 receptors with a precision that has made cannabis the most studied plant in ECS research by a considerable margin.
This is not cultural bias dressed up as science. The research follows the receptor fit — and the receptor fit is exceptional.
But cannabis’s advantage isn’t only about cannabinoids. The plant also produces an extraordinary range of terpenes — aromatic compounds that contribute their own biological activity — and flavonoids, which have antioxidant and anti-inflammatory properties. The full chemical profile of cannabis is not one remarkable compound. It is a remarkably complex system of compounds that, as we’ll explore in the next section, work together in ways that no single molecule can replicate alone.
Cannabis Is Exceptional Across the Board
It is worth stepping back for a moment to appreciate the full picture. Cannabis is not remarkable simply because it produces phytocannabinoids. It is remarkable because of everything it produces simultaneously.
Hemp seeds are one of the few plant sources of complete protein — containing all nine essential amino acids your body cannot make on its own. The fatty acid profile of hemp oil sits at an omega-3 to omega-6 ratio that mirrors almost exactly what human biology requires. The plant produces fiber, minerals, antioxidant flavonoids, and biologically active terpenes alongside its cannabinoids — not as separate features, but as parts of an integrated chemical system that humans have been drawing on for at least 10,000 years across nearly every culture on earth.
People didn’t know why cannabis was useful for so many things. They just knew that it was. The science has spent the last several decades catching up to what traditional use already understood: this is not a plant that does one thing well. It is a plant that does an extraordinary number of things — and does most of them better than anything else in the kingdom.
The Phytocannabinoid Family
Cannabis produces over 100 distinct cannabinoids. Most exist in quantities too small to produce meaningful physiological effect. Five, however, have been studied enough to understand — at least in meaningful part — what they do, how they do it, and why they matter. Each one interacts with the ECS differently. Each one has a distinct therapeutic profile. And as you’ll see in the next section, they work considerably better together than any one of them works alone.
CBD — Cannabidiol
CBD is the most researched phytocannabinoid after THC, and the one most people encounter first. It is non-psychoactive — meaning it does not produce intoxication — which has made it both more accessible and, paradoxically, more misunderstood. Non-psychoactive is not the same as inert.
CBD does not bind directly to CB1 or CB2 receptors the way THC does. Instead it works more indirectly — modulating how those receptors respond to other signals, inhibiting the enzyme that breaks down anandamide, and interacting with a range of non-ECS receptors including serotonin and vanilloid receptors that influence pain perception, mood, and inflammation. This indirect mechanism is part of why CBD’s effects are broad rather than targeted — it supports the ECS rather than substituting for it.
The strongest clinical evidence for CBD involves epilepsy. Epidiolex, a pharmaceutical-grade CBD formulation, received FDA approval in 2018 for two rare and severe forms of childhood epilepsy — Dravet syndrome and Lennox-Gastaut syndrome — after clinical trials demonstrated significant seizure reduction. This is not anecdote. This is a randomized controlled trial, FDA review, and approved medication.
Beyond epilepsy, the research on CBD covers anxiety, inflammation, pain, and sleep — with results that range from promising to preliminary depending on the condition and the study quality. The honest summary: CBD has demonstrated real effects in real trials. The full map of what it does, at what doses, for which conditions, is still being drawn.
THC — Tetrahydrocannabinol
THC is the primary psychoactive compound in cannabis — the one responsible for the intoxication most people associate with the plant. That effect is real, documented, and worth understanding mechanistically: THC binds directly to CB1 receptors, which are concentrated in the brain regions governing mood, memory, pain perception, and appetite. When THC activates those receptors, it produces the cognitive and perceptual shifts associated with being high.
But this is one effect of one mechanism. It is not the whole story.
THC also has well-documented analgesic properties — it modulates pain signaling through CB1 receptors in ways that have made it clinically relevant for chronic pain, neuropathic pain, and pain associated with conditions like multiple sclerosis and cancer. It stimulates appetite through CB1 activity in the hypothalamus — which has made it medically useful for patients experiencing cachexia, the severe appetite and weight loss associated with cancer and HIV. It has demonstrated anti-nausea effects significant enough that synthetic THC analogs have been FDA-approved for chemotherapy-induced nausea since the 1980s. And emerging research suggests neuroprotective properties — THC’s interaction with the ECS may support the brain’s own mechanisms for managing neuroinflammation.
CBG — Cannabigerol
CBG is sometimes called the mother cannabinoid — and for good biochemical reason. CBGA, its acidic precursor, is the molecular starting point from which cannabis synthesizes most other cannabinoids including CBD and THC. By the time a cannabis plant reaches maturity, most of its CBGA has already been converted into other compounds, which is why CBG typically appears in small concentrations in mature plants.
CBG interacts with both CB1 and CB2 receptors, though with less affinity than THC. Early research — and it is early — suggests potential in several areas: antibacterial properties, including activity against drug-resistant strains of bacteria; neuroprotective effects in animal models of neurodegenerative disease; and anti-inflammatory activity mediated through CB2 receptor interaction.
There is also emerging research on CBG’s potential role in cognitive clarity. Brain fog — the difficulty concentrating, mental sluggishness, and cognitive fatigue increasingly recognized as a symptom of neuroinflammation — may respond to CBG’s anti-inflammatory activity through CB2 receptors in the brain. The research is preliminary, but the mechanism is plausible and the direction is promising.
The honest caveat: most CBG research to date involves cell cultures and animal models. Human clinical trials are limited. CBG is a genuinely promising cannabinoid with a plausible mechanism and early supportive evidence — and it deserves more research than it has currently received.
CBN — Cannabinol
CBN is not synthesized directly by the cannabis plant the way other cannabinoids are. It is a degradation product — what THC becomes as it oxidizes over time through exposure to heat, light, and air. CBN is mildly psychoactive — significantly less so than THC — and has a lower affinity for CB1 receptors.
CBN is perhaps most publicly associated with sleep, a reputation that preceded the science and has been only partially validated by it. Early research does suggest sedative properties, but some researchers attribute the sleep-promoting effects historically observed in CBN-rich cannabis to the terpene profiles of aged cannabis rather than CBN itself. The sleep association is not unfounded — but it is not as clean as the wellness market often presents it.
Where CBN research is more consistent: antibacterial properties, appetite stimulation, and potential anti-inflammatory effects through CB2 receptor interaction. Watch this space — but watch it honestly.
CBC — Cannabichromene
Early research suggests anti-inflammatory, analgesic, and potentially antidepressant properties — the latter through a mechanism involving increased anandamide levels. There is also preliminary research suggesting CBC may support neurogenesis — the growth of new brain cells — in adult neural stem progenitor cells. CBC is the most understudied of the five cannabinoids covered here, and the research reflects that. What makes it worth including is precisely its distinct mechanism — it suggests that a complete phytocannabinoid profile does things that no subset of cannabinoids can fully replicate.
CBC is among the least publicly recognized of the major cannabinoids, which is inversely proportional to how interesting its mechanism is. Unlike CBD and THC, CBC has very low affinity for CB1 and CB2 receptors. Instead it interacts primarily with other receptor types — TRPA1 and TRPV1 — that are involved in pain perception and inflammation. This makes CBC’s mechanism distinct from every other cannabinoid in this family.
The Supporting Cast: Terpenes and Flavonoids
Walk through a pine forest. Peel an orange. Crush a sprig of lavender between your fingers. Grind black pepper over your dinner.
4dWhat you’re smelling in every one of those moments is terpenes — aromatic compounds produced by plants as part of their chemical defense and communication systems. Terpenes deter predators, attract pollinators, signal neighboring plants, and protect against UV radiation and pathogens. They are, in the most literal sense, the language plants use to interact with the world around them.
Terpene production evolved across the plant kingdom hundreds of millions of years ago — as defense, as communication, as survival. Cannabis simply evolved to produce them in extraordinary concentration and diversity, making it one of the most terpene-rich plants on earth. A single cannabis plant can contain over 200 distinct terpenes.
But terpenes are not merely aromatic. They have their own biological activity — interacting with receptors, modulating neurotransmitter systems, and influencing how cannabinoids behave in your body. Understanding them changes how you think about botanical medicine generally: the smell is not decoration. It is information.
Myrcene
Myrcene is the most abundant terpene in most cannabis varieties — and it is far from exclusive to cannabis. You’ll find it in hops, mango, thyme, and lemongrass. The research on myrcene suggests sedative and muscle-relaxant properties, with some studies indicating it may enhance cell membrane permeability — potentially allowing cannabinoids to cross the blood-brain barrier more efficiently. Experienced cannabis users have long noted that eating mango before consuming cannabis intensifies and extends the experience — a folk observation that turns out to have a plausible biochemical basis in myrcene.
Limonene
Limonene is the primary terpene in citrus fruit — the sharp, bright aroma of a freshly peeled lemon or orange. It is also produced by juniper, peppermint, and rosemary, and appears in meaningful concentrations in certain cannabis varieties. The research covers elevated mood, anxiety reduction, and anti-inflammatory effects. It appears to interact with serotonin and dopamine receptors — the neurotransmitter systems most associated with mood regulation. The mood-lifting association with citrus that humans have relied on intuitively for centuries turns out to have a receptor-level explanation.
Linalool
Linalool is lavender’s primary terpene, also produced by over 200 plant species including coriander, basil, and birch trees. The research on linalool is among the most developed of any terpene. It demonstrates anxiolytic — anxiety-reducing — effects in multiple animal models, with human studies supporting its use for stress and sleep. It modulates GABA receptor activity — the same inhibitory neurotransmitter system targeted by benzodiazepines — which provides a plausible mechanism for its calming properties. It also shows analgesic effects through interaction with adenosine receptors. The reason aromatherapy has built an entire practice around lavender is not mysticism. It is linalool, and linalool has a documented mechanism.
Beta-Caryophyllene
Beta-caryophyllene occupies a unique position in the terpene family — because it is the only terpene known to bind directly to cannabinoid receptors. Specifically CB2 receptors. This makes it simultaneously a terpene and a functional cannabinoid. You encounter it constantly: it is dominant in black pepper, abundant in cloves, rosemary, and copaiba. Every time you’ve ground black pepper over food you’ve been activating CB2 receptors. The anti-inflammatory implications are significant — CB2 activation is one of the primary mechanisms by which the ECS modulates immune response and systemic inflammation.
Alpha-Pinene
Alpha-pinene is the most abundant terpene in the natural world — the primary aromatic compound of pine forests. Also found in rosemary, eucalyptus, and sage. Research suggests bronchodilation — it opens airways — and cognitive support: alpha-pinene inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine, a neurotransmitter critical to memory and learning. There is also evidence suggesting alpha-pinene may partially counteract some of THC’s short-term memory effects, which has implications for understanding cannabis variety profiles.
Terpinolene
Terpinolene appears primarily in certain sativa-leaning cannabis varieties. Outside cannabis you’ll find it in apples, cumin, lilac, and tea tree. The research is less developed than the others profiled here — worth saying plainly. What exists suggests antioxidant properties and mild sedative effects in animal models. Terpinolene illustrates something important: the terpene profile of a cannabis plant varies by variety, growing conditions, and processing — and that variation has biological consequences.
Flavonoids — The Underrecognized Layer
Flavonoids are a large class of plant compounds found across the entire plant kingdom — in fruits, vegetables, grains, and herbs. They function primarily as antioxidants and pigments. In human biology, flavonoids have been associated with anti-inflammatory, antioxidant, and cardioprotective effects.
Cannabis produces over 20 identified flavonoids, including some found only in cannabis, called cannaflavins. Cannaflavin A and Cannaflavin B have demonstrated anti-inflammatory activity in research, with one study suggesting Cannaflavin A inhibits inflammatory compounds at a rate significantly more potent than aspirin by weight. That research is early and should not be overstated — but it is a real finding with a documented mechanism.
Beyond cannaflavins, cannabis also contains quercetin — found in apples, onions, and berries, with well-documented antioxidant and anti-inflammatory properties — and kaempferol, found in broccoli, kale, and spinach, associated with cardiovascular and neuroprotective effects. The flavonoid layer of cannabis is not separate from its therapeutic profile. It is part of it.
The Complexity Principle
Or, Why the Whole Is Greater Than the Sum — But Why Isolation Still Has Its Place
Modern medicine has a reductionist habit. Find the active compound. Isolate it. Standardize it. Deliver it in a precise, measurable dose. This approach has produced remarkable medicine — penicillin, insulin, antiretrovirals, Epidiolex — and it will continue to do so. Isolation is not bad science. It is a specific kind of science, with specific strengths, and specific limitations.
Understanding both is what botanical medicine actually requires.
So, Complexity Works
Plants do not produce single compounds. They produce ecosystems of compounds — cannabinoids, terpenes, flavonoids, alkaloids, fatty acids — that evolved together, interact with each other, and produce effects in combination that none of them produces alone.
These interactions are not accidental. They are the result of millions of years of co-evolution between plant chemistry and animal biology. The compounds in a plant didn’t develop in isolation from each other — they developed as a system. And when that system reaches human receptors, it behaves like a system: compounds modulating each other’s activity, filling gaps in each other’s receptor coverage, extending each other’s duration, and buffering each other’s potential adverse effects.
This is why whole-plant botanical preparations have consistently outperformed isolated compounds in certain research contexts. Researchers have a name for this phenomenon in cannabis research: the entourage effect. But the principle it describes is not cannabis-specific. It is a fundamental characteristic of how plant chemistry interacts with human biology.
But Why Isolation Also Works
Isolated compounds offer something whole plants cannot: precision. When a condition requires a specific, measurable, reproducible dose of a specific compound — when the margin between therapeutic effect and adverse effect is narrow, when interactions need to be controlled, when a patient population is vulnerable — isolation is not a compromise. It is the right tool.
Many people reading this page manage serious, chronic conditions with medications that work — that have been tested, refined, and calibrated to their specific biology over time. Those medications are not obstacles to botanical medicine. They are part of the complete picture of that person’s health. Botanical supplements, for those people, need to fit into that picture carefully — not replace it.
What You Need to Know Before Combining Both
If you are currently taking prescription medications — and statistically, most adults reading this are — there is one practical reality you need to understand before adding any botanical supplement to your routine.
Plants are pharmacologically active. That is the entire point of this page. And pharmacologically active compounds interact with each other — including with pharmaceutical drugs.
CBD is the clearest example. It inhibits a family of liver enzymes called cytochrome P450 — the same enzymes responsible for metabolizing a significant percentage of common pharmaceutical drugs, including blood thinners, certain antidepressants, and some heart medications. When CBD slows those enzymes, it can affect how your medications are processed — potentially raising or lowering their effective concentration in your bloodstream. This is not a reason to avoid CBD. It is a reason to have a conversation with your doctor or pharmacist before adding it.
SownScience will always tell you when a plant compound has known interactions with common medications. We will never tell you to replace a medication that is working. And we will always recommend that you bring your botanical supplement questions to a qualified healthcare provider — not because the science isn’t accessible, but because your health history is specific to you, and general information is never a substitute for personalized medical advice.
Complexity and isolation are not opposites. They are different answers to different questions — and knowing which question you’re asking is where good botanical medicine begins.
Putting It Into Practice: A Brief Orientation
The science on this page translates directly into the products you’ll encounter — and knowing a few key terms makes the difference between shopping with confidence and guessing.
Full-spectrum products contain the complete chemical profile of the plant — cannabinoids, terpenes, flavonoids, and trace compounds including THC within legal limits. They preserve the complexity principle in practice.
Broad-spectrum products retain most of the plant’s chemical profile but have THC removed — an option for those who want the benefit of multiple compounds without any THC present.
Isolate products contain a single purified compound — CBD isolate, for example — with everything else removed. Precise, consistent, and appropriate for specific circumstances where a single known compound is what’s needed.
None of these is universally superior. Each serves a different purpose for a different person in different circumstances — which is exactly what the complexity principle predicts.
What matters most, regardless of which type you choose, is verification: a product is only as good as its third-party testing. We’ll cover how to read a Certificate of Analysis — the document that proves what’s actually in a product — and what to look for when evaluating any botanical supplement, in our free guide.